Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2009-012039-14Phase 4Completed
Phase 4, open-label trial of formoterol in asthma (3 arms), sponsored by Respiratory and Allergy Research Unit. Primary endpoints: Serum formoterol concentration and Urine formoterol concentration. Started May 2009; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2009-012039-14.